“…All patient in the studies reported by Townsend, Sengezer et al, and Manrique et al experienced adverse events (Manrique et al, 2018; Sengezer et al, 1997; Townsend, 1987). In contrast, Bishop et al, Serel et al, Turgut et al, Topalan and Ermis, Hamdi et al, Yu et al, Zhang et al, 2012a; Lai et al, Karisdag et al, Hodgkinson et al, Lu et al, and Ciudad et al reported no adverse events (0%) (Bishop et al, 2018; Ciudad et al, 2020; Zhang et al, 2012b; Hamdi et al, 2000; Hodgkinson et al, 1994; Karşıdağ et al, 2011; Lai et al, 1991; Lu et al, 2013; Serel et al, 2006; Topalan & Ermis, 2001; Turgut et al, 2010; Yu et al, 2012). The adverse events included n = 6 instances of partial skin graft loss, n = 5 cases with prolonged pain, n = 4 instances of hematoma, n = 2 instances of venous thrombosis salvaged with vein grafts, n = 1 partial graft loss, n = 1 reports of free flap failure requiring amputation, n = 1 instance of secondary cancellous bone graft due to nonunion, and n = 1 instance of seroma.…”